Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
1999 · British Journal of Cancer · 28 citations
https://doi.org/10.1038/sj.bjc.6690598
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
102
Citations
4
h-index
3
i10-index
A. Flavin is an academic researcher from Mercy University Hospital. The author has contributed to research in topics: Prostate Cancer Diagnosis and Treatment & Prostate Cancer Treatment and Research & Anesthesia and Pain Management. The author has an h-index of 4, co-authored 12 publications.
Click to start Chat